Abstract
Objectives: Few studies have examined methods by which breast cancers are detected, and only one study has been published on predictors of those methods. This study examined patterns and predictors of breast cancer detection methods during 1990–1992 among women age 20–44.
Methods: In-person interview and medical record data were obtained during a population-based case–control study of 1619 women newly diagnosed with breast cancer in three areas of the United States (US).
Results: Seventy-one percent of the cancers were identified by self-detection, 9% by routine clinical breast exam (CBE), and 20% by routine mammography. Cancers detected by mammography and CBE, but not those detected by breast self-exam, were much more likely to be early-stage. Detection by mammography increased with age, and a history of mammography use was associated with detection by mammography or CBE. Several commonly studied predictors of screening utilization in the US population were associated with CBE detection, but were less clearly related to or unrelated to mammography detection.
Conclusion: Findings suggest that, during the 1990s in the US, most breast cancers among women under age 45, including those age 40–44, were self-detected. Few factors other than age and prior screening are verified predictors of method of breast cancer detection.
Similar content being viewed by others
References
US Preventive Services Task Force (1996) Guide to Clinical Preventive Services, 2nd edn. Baltimore, MD: Williams & Wilkins.
Leitch AM, Dodd GD, Constanza M, et al. (1997) American cancer society guidelines for early detection of breast cancer: update 1997. CA-Cancer J Clin 47: 150–153.
Rimer BK, Schildkraut J, Hiatt RA (2000) Cancer screening. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer Principles and Practices of Oncology, 6th edn. Philadelphia, PA: Lippincott-Williams & Wilkins.
Feig SA (1987) Mammography screening: published guidelines and actual practice. Recent Results Cancer Res 105: 78–84.
King AS (1989) Not everyone agrees with new mammographic screening guidelines designed to end confusion. JAMA 262: 1154–1155.
Dodd GD (1992) American Cancer Society guidelines on screening for breast cancer: an overview. Cancer 69s: 1885s–1887s.
Eastman P (1997) NCI adopts new mammography screening guidelines for women. J Natl Cancer Inst 89: 538–540.
Baines CJ, Miller AB (1997) Mammography versus clinical examination of the breasts. J Natl Cancer Inst Monogr 22: 125–129.
Barton MB, Harris R, Fletcher SW (1999) Does this patient have breast cancer? The screening clinical breast examination: should it be done? How? JAMA 282: 1270–1280.
Howard J (1987) Using mammography for cancer control: an unrealized potential. CA Cancer J Clin 37: 33–48.
White E, Urban N, Taylor V (1993) Mammography utilization, public health impact, and cost-effectiveness in the United States. Annu Rev Publ Health 14: 605–633.
Breen N, Kessler L (1996) Trends in cancer screening — United States, 1987 and 1992. Oncology 10: 328–330.
Blackman DK, Bennett EM, Miller DS (1999) Trends in self-reported use of mammograms (1989–1997) and Papanicolaou tests (1991–1997) — United States. In: CDC Surveillance Summaries, MMWR 48(SS-6): 1–23.
Vernon SW, Laville EA, Jackson GL (1990) Participation in breast screening programs: a review. Soc Sci Med 30: 1107–1118.
Anderson LM, May DS (1995) Has the use of cervical, breast, and colorectal cancer screening increased in the United States? Am J Public Health 85: 840–842.
Ackerman SP, Brackbill RM, Bewerse BA, Cheal NE, Sanderson LM (1992) Cancer screening behaviors among US women: breast cancer, 1987–1989, and cervical cancer, 1988–1989. In: CDC Surveillance Summaries, MMWR 41: 17–34.
Bastani R, Kaplan CP, Maxwell AE, Nisenbaum R, Pearce J, Marcus AC (1995) Initial and repeat mammography screening in a low income multi-ethnic population in Los Angeles. Cancer Epidemiol Biomarkers Prev 4: 161–167.
Beaulieu M-D, Beland F, Roy D, Falardeau M, Hebert G (1996) Factors determining compliance with screening mammography. Can Med Assoc J 154: 1335–1343.
Bloom JR, Grazier K, Hodge F, Hayes WA (1991) Factors affecting the use of screening mammography among African American women. Cancer Epidemiol Biomarkers Prev 1: 75–82.
Costanza ME, Stoddard A, Gaw VP, Zapka JG (1992) The risk factors of age and family history and their relationship to screening mammography utilization. J Am Geriatr Soc 40: 774–778.
Frazier EL, Jiles RB, Mayberry R (1996) Use of screening mammography and clinical breast examinations among black, Hispanic, and white women. Prev Med 25: 118–125.
Horton JA, Cruess DF, Romans MC (1996) Compliance with mammography screening guidelines: 1995 Mammography Attitudes and Usage Study Report. Women's Health Issues 6: 239–245.
Jepson C, Kessler LG, Portnoy B, Gibbs T (1991) Black-white differences in cancer prevention knowledge and behavior. Am J Public Health 81: 501–504.
Kaplan KM, Weinberg GB, Small A, Herndon JL (1991) Breast cancer screening among relatives of women with breast cancer. Am J Public Health 81: 1174–1179.
Lerman C, Daly M, Sands C, et al. (1993) Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst 85: 1074–1080.
Phillips KA, Kerlikowske K, Baker LC, Chang SW, Brown ML (1998) Factors associated with women's adherence to mammography screening guidelines. Health Serv Res 33: 29–53.
Rakowski W, Pearlman D, Rimer BK, Ehrich B (1995) Correlates of mammography among women with low and high socioeconomic resources. Prev Med 24: 149–158.
Rakowski W, Clark MA (1998) Do groups of women aged 50 to 75 match the national average mammography rate? Am J Prev Med 15: 187–197.
Rimer BK, Trock B, Engstrom PF (1991) Why do some women get regular mammograms? Am J Prev Med 7: 69–74.
Schoen RE, Marcus M, Braham RL (1994) Factors associated with the use of screening mammography in a primary care setting. J Commun Health 19: 239–252.
Casey S, Plomer K, Tenney M (1995) Breast and Cervical Cancer Screening: Barriers and Use among Specific Populations. Denver, CO: AMC Cancer Research Center.
Yabroff KR, Mandelblatt JS (1999) Interventions targeted toward patients to increase mammography use. Cancer Epidemiol Biomarkers Prev 8: 749–757.
Mandelblatt JS, Yabroff KR (1999) Effectiveness of interventions designed to increase mammography use: a meta-analysis of provider-targeted strategies. Cancer Epidemiol Biomarkers Prev 8: 759–767.
Wyatt SW, Long DM, Lee NC, et al. (1996) State legislation related to breast cancer: 1980–1994. J Public Health Manage Pract 2: 64–69.
Henson RM, Wyatt SW, Lee NC (1996) The National Breast and Cervical Cancer Early Detection Program: a comprehensive public health response to two major health issues for women. J Public Health Manage Pract 2: 36–47.
US Department of Health and Human Services (1995) Healthy People 2000 Midcourse Review and 1995 Revisions. Washington, DC: US Government Printing Office.
Kessler LG, Feuer EJ, Brown ML (1991) Projections of the breast cancer burden to US women: 1990–2000. Prev Med 20: 170–182.
Miller BA, Feuer EJ, Hankey BF (1991) The increasing incidence of breast cancer since 1982: relevance of early detection. Cancer Causes Control 2: 67–74.
Liff JM, Sung JFC, Chow W-H, Greenberg RS, Flanders WD (1991) Does increased detection account for the rising incidence of breast cancer? Am J Public Health 81: 462–465.
Ballard-Barbash R, Taplin SH, Yankaskas BC, et al. (1997) Breast Cancer Surveillance Consortium: a national mammography and outcomes database. Am J Roentgenol 169: 1001–1008.
Senie RT, Lesser M, Kinner DW, Rosen PP (1994) Method of tumor detection influences disease-free survival of women with breast carcinoma. Cancer 73: 1666–1672.
Nemoto T, Natarajan N, Smart CR, Mettlin C, Murphy GP (1982) Patterns of breast cancer detection in the United States. J Surg Oncol 21: 183–188.
Reeves MJ, Newcomb PA, Remington PL, Marcus PM (1995) Determinants of breast cancer detection among Wisconsin (United States) women, 1988–90. Cancer Causes Control 6: 103–111.
McPherson CP, Swenson KK, Jolitz G, Murray CL (1997) Survival of women ages 40–49 years with breast carcinoma according to method of detection. Cancer 79: 1923–1932.
Spratt JS, Greenberg RA, Heuser LS (1986) Geometry, growth rates, and duration of cancer and carcinoma in situ of the breast before detection by screening. Cancer Res 46: 970–974.
Brekelmans CTM, Peeters PHM, Faber JAJ, Deurenberg JJM, Collette HJA (1994) The epidemiological profile of women with an interval cancer in the DOM screening programme. Breast Cancer Res Treat 30: 223–232.
Tabar L, Fagerberg G, Chen HH, Duffy SW, Gad A (1996) Tumour development, histology and grade of breast cancers: prognosis and progression. Int J Cancer 66: 413–419.
Wohlfahrt J, Andersen PK, Mouridsen HT, Adami H-O, Melbye M (1999) Reproductive history and stage of breast cancer. Am J Epidemiol 150: 1325–1330.
Weiss HA, Brinton LA, Brogan D, et al. (1996) Epidemiology of in situ and invasive breast cancer in women aged under 45. Br J Cancer 73: 1298–1305.
National Institutes of Health Consensus Development Panel (1997) National Institutes of Health Consensus Development Conference statement: breast cancer screening for women ages 40–49, January 21–23, 1997. J Natl Cancer Inst Monogr 22: vii–xii.
Berry DA (1998) Benefits and risks of screening mammography for women in their forties: a statistical appraisal. Commentary. J Natl Cancer Inst 90: 1431–1439.
Forrest AP, Alexander FI (1995) A question that will not go away: at what age should mammographic screening begin [editorial]. J Natl Cancer Inst 87: 1195–1197.
Taubes G (1997) The breast-screening brawl. Science 275: 1056–1059.
National Cancer Advisory Board (1997) National Cancer Advisory Board (NCAB) Mammography Recommendations for Women ages 40–49. Bethesda, MD: National Cancer Institute.
Hendrick RE, Smith RA, Rutledge JH, Smart CR (1997) Benefit of screening mammography in women aged 40–49: a new metaanalysis of randomized controlled trials. Natl Cancer Inst Monogr 22: 87–92.
Kerelikowske K (1997) Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: comparison of relative and absolute benefit. Natl Cancer Inst Monogr 22: 79–86.
Dickersin K (1999) Breast screening in women aged 40–49 years: what next? Lancet 353: 1896–1897.
US Department of Health and Human Services (2000) Healthy People 2010 (Conference Edition). Washington, DC: US Government Printing Office.
US Preventive Services Task Force (1989) Guide to Clinical Preventive Services. Baltimore, MD: Williams & Wilkins.
Auvinen A, Elovainio L, Hakama M (1996) Breast self-examination and survival from breast cancer: a prospective follow-up study. Breast Cancer Res Treat 38: 161–168.
Thomas DB, Gao DL, Self SG, et al. (1997) Randomized trial of breast self-examination in Shanghai: methodology and preliminary results. J Natl Cancer Inst 89: 355–365.
UK Trial of Early Detection of Breast Cancer Group (1999) 16-year mortality from breast cancer in the UK Trial of Early Detection of Breast Cancer. Lancet 353: 1909–1914.
Brinton LA, Daling JR, Liff J, et al. (1995) Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst 87: 827–835.
Stange KC, Flocke SA, Goodwin MA (1998) Opportunistic preventive services delivery. J Fam Pract 46: 419–424.
US Department of Commerce (1980) Standard Occupational Classification Manual, 1980. Washington, DC: US Government Printing Office.
US Department of Health and Human Services (1991) Annual update of the HHS poverty income guidelines. Fed Reg 56: 6859–6861.
Ries LAG, Eisner MP, Kosary CL, et al., eds (2000) SEER Cancer Statisties Review, 1973–1994. Bethesda, MD: National Cancer Institute.
Hosmer DW, Lemeshow S (1989) Applied Logistic Regression. New York: John Wiley & Sons.
SAS Institute, Inc (1990) SAS User's Guide, Version 6, 4th edn. Cary, NC: SAS.
Hellman S (1994) Natural history of small breast cancers. J Clin Oncol 12: 2229–2234.
Mickey RM, Greenland S (1989) The impact of confounder selection criteria on effect estimation. Am J Epidemiol 129: 125–137.
Newell SA, Girgis A, Sanson-Fisher RW, Savolainen NJ (1999) The accuracy of self-reported health behaviors and risk factors relating to cancer and cardiovascular disease in the general population, a critical review. Am J Prev Med 17: 211–229.
Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA (1995) Continued local recurrence of carcinoma 15 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 75: 1197–1200.
Chen VW, Correa P, Kurman RJ, et al. (1994) Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev 3: 127–135.
Schiller PL, Levin JS (1988) Is there a religious factor in health care utilization? A review. Soc. Sci Med 27: 1369–1379.
Fink R, Shapiro S, Lewison J (1968) The reluctant participant in a breast cancer screening program. Public Health Rep 83: 479–490.
Haynes MA, Smedley BD, eds (1999) The Unequal Burden of Cancer. Washington, DC: National Academy Press.
Helzlsouer KJ (1995) Early detection and prevention of breast cancer. In: Greenwald P, Kramer BS, Weed DL, eds. Cancer Prevention and Control. New York: Marcel Dekker.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Coates, R.J., Uhler, R.J., Brogan, D.J. et al. Patterns and predictors of the breast cancer detection methods in women under 45 years of age (United States). Cancer Causes Control 12, 431–442 (2001). https://doi.org/10.1023/A:1011218005063
Issue Date:
DOI: https://doi.org/10.1023/A:1011218005063